To highlight lessons for care delivery in managing drug-resistant tuberculosis (DR-TB) through a detailed case study, emphasizing its significance in improving patient outcomes.
Key Findings:
Early use of rapid molecular diagnostics is crucial for timely and effective treatment, preventing prolonged morbidity.
Multidisciplinary governance is essential for aligning surgical and toxicity management decisions, ensuring comprehensive care.
TB care should extend beyond microbiological cure to include structured rehabilitation and disability support, addressing long-term patient needs.
Interpretation:
The case illustrates significant failures in the TB care cascade, emphasizing the need for improved diagnostic practices and coordinated care to prevent prolonged and toxic treatment pathways.
Limitations:
Lack of baseline rapid molecular diagnostics led to delayed and ineffective treatment; implementing routine diagnostics could mitigate this.
Fragmented referral processes resulted in inappropriate surgical interventions; establishing clear referral protocols is essential.
The absence of therapeutic drug monitoring during treatment contributed to adverse effects; regular monitoring should be standard practice.
Conclusion:
The case underscores the importance of addressing systemic gaps in DR-TB management through multidisciplinary approaches to improve patient outcomes and reduce morbidity.
